WSJ logo
Forbes logo
Fox News logo
CNN logo
Bloomberg logo
Los Angeles Times logo
Washington Post logo
The Epoch Times logo
Telemundo logo
New York Times
NY Post logo
NBC logo
Daily Beast logo
USA Today logo
Miami Herald logo
CNBC logo
Dallas News logo

FDA Mock Inspections

Our Lawyers and Consultants Help FDA-Regulated Companies Conduct Mock Inspections So That They’re Prepared for the Real Thing

Nick Oberheiden
Attorney Nick Oberheiden
FDA Mock Inspections Team Lead
Lynette Byrd
Attorney Lynette Byrd
FDA Mock Inspections Team Lead
Former DOJ Attorney
Attorney John Sellers
John W. Sellers
FDA Mock Inspections Team Lead
Former Senior DOJ Trial Attorney

The U.S. Food and Drug Administration (FDA) regularly conducts inspections in order to assess companies’ compliance with the Food, Drug, and Cosmetic Act (FDCA) and all other pertinent laws and regulations. Medical device manufacturers, pharmaceutical companies, and other FDA-regulated entities can face inspections at various stages—from the premarket submission process through the FDA’s postmarket surveillance focused on ensuring consumer and patient safety. These inspections can present substantial risks, so companies need to be confident that they are prepared. A key step in this process involves conducting mock FDA inspections.

Conducting an effective mock FDA inspection requires a clear and comprehensive understanding of what the FDA inspectors will be looking for when it scrutinizes the company’s facilities and operations during a real FDA inspection. At Oberheiden P.C., our team has experience not only advising companies regarding FDA regulations compliance, but also conducting inspections at the FDA. With a former FDA Director of Compliance and former FDA Investigator on your side, you can be confident that your company’s mock inspections are providing an accurate assessment of its risks during an actual FDA inspection—and you can update your company’s FDA compliance program, taking corrective and preventive actions accordingly.

5 Important Reasons to Conduct FDA Mock Inspections

Conducting FDA mock inspections is about much more than just “checking a box” on your company’s regulatory compliance checklist. When conducted appropriately, mock inspections afford several direct benefits, including:

1. Identifying Any Compliance Program Shortcomings Before They Lead to Problems

The last thing you want during an FDA inspection is a surprise. These surprises are rarely good—and, more often than not, they cause substantial setbacks in companies’ efforts to market FDA-regulated devices, drugs, and other products. By conducting FDA mock inspections, companies can identify any shortcomings in their compliance programs before these shortcomings lead to problems.

2. Ensuring Compliance with All Applicable FDA Laws and Regulations

Conducting mock inspections also allows companies to ensure compliance with all applicable FDA laws and regulations. FDA-regulated companies need to prioritize compliance, and they need to be confident in all aspects of their compliance programs.

3. Generating Documentation of the Company’s Good-Faith Compliance Efforts

Along with ensuring compliance, conducting FDA mock inspections also allows companies to generate documentation of their good-faith compliance efforts. When the FDA conducts inspections, it expects companies to be able to affirmatively demonstrate compliance, so this documentation is crucial. Simply having documented policies and procedures isn’t enough—companies must also be able to show that they are taking proactive steps to implement these policies and procedures on an ongoing basis.

4. Avoiding Unnecessary Risks, Costs, and Delays Due to FDA Inspections

If the FDA uncovers compliance failures during an inspection, this can lead to risks, costs, and delays that could—and should—have been avoided. Mock inspections serve to help companies avoid these issues, bring their products to market as quickly as possible, and keep them on the market post-FDA authorization or approval.

5. Maximizing the Profitability of the Company’s FDA-Regulated Business

Ultimately, by maximizing the efficiency of the premarket submission process and ensuring that companies’ products won’t be subject to recalls or market withdrawals, FDA mock inspections help to maximize the profitability of companies’ FDA-regulated business. At Oberheiden P.C., we prioritize cost-effectiveness, and we rely on our lawyers’ and consultants’ experience to conduct mock inspections that drive value for our clients.

FDA Mock Inspections: Our Process

As a law firm with a network of compliance consultants that includes former FDA personnel, we are able to conduct mock inspections differently from most other organizations. Unlike non-law firms, we are able to provide legal advice during (and after) the process. Additionally, unlike law firms that do not have former FDA personnel on their team, we are able to provide insights based on first-hand experience of how FDA inspections work from the inside out.

With this in mind, while we take a highly custom-tailored approach to legal representation, our process for conducting FDA mock inspections generally involves:

1. Assessing the Scope and Nature of Our Client’s FDA-Regulated Operations

For FDA-regulated entities, the risks they face during an inspection depend on several unique aspects of their FDA-regulated operations. As a result, before we do anything else, we begin by identifying the scope and nature of our clients’ operations that are subject to the FDA’s oversight.

2. Examining Our Client’s FDA Compliance Program, Practices, and Procedures

Another key preliminary step in the process involves examining our client’s FDA compliance program, practices, and procedures. The FDA will examine these as well, so companies need to be confident that they are capable of withstanding the Administration’s scrutiny. If we identify any substantial shortcomings, we help our client address these shortcomings before conducting our mock inspection.

3. Developing an FDA Mock Inspection Plan and Strategy

Since each company’s FDA-regulated operations are unique, each FDA mock inspection requires a custom-tailored plan and strategy. We develop our mock inspection plan and strategy based on what we believe the FDA would do in preparation for conducting a real-world inspection.

4. Conducting the Mock Investigation

Once we’ve laid the groundwork, we will conduct an FDA mock inspection. This will involve examining all aspects of the company’s facility, quality standards, manufacturing and packaging processes, documentation practices, and other relevant practices and procedures. It will also involve conducting mock interviews, document requests, and other investigative steps that the FDA will take when it assesses the company’s compliance.

5. Going Over the Results and Outlining Next Steps

Finally, after completing the FDA mock inspection process, we will go over the results with our client and outline our client’s next steps. Depending on the circumstances, these next steps could range from maintaining the status quo to implementing new or revised FDA compliance policies and procedures. Here, too, we take a custom-tailored approach focused on helping our client establish, maintain, and document full FDA compliance based on its specific risks and needs.

Put our highly experienced team on your side

Dr. Nick Oberheiden
Dr. Nick Oberheiden

Founder

Attorney-at-Law

Lynette S. Byrd
Lynette S. Byrd

Former DOJ Trial Attorney

Partner

Brian J. Kuester
Brian J. Kuester

Former U.S. Attorney

Kevin McCarthy
Hon. Kevin McCarthy

55th Speaker, U.S. House of Representatives (ret.)

Government Consultant

Mike Pompeo
Mike Pompeo

Of Counsel

Former U.S. Secretary of State

John W. Sellers
John W. Sellers

Former Senior DOJ Trial Attorney

Linda Julin McNamara
Linda Julin McNamara

Federal Appeals Attorney

Nicholas B. Johnson
Nicholas B. Johnson

Former Prosecutor

Roger Bach
Roger Bach

Former Special Agent (DOJ)

Chris Quick
Chris J. Quick

Former Special Agent (FBI & IRS-CI)

Michael S. Koslow
Michael S. Koslow

Former Supervisory Special Agent (DOD-OIG)

Ray Yuen
Ray Yuen

Former Supervisory Special Agent (FBI)

FAQs: Conducting Mock Inspections to Assess and Document FDA Compliance

Are FDA-Regulated Companies Required to Conduct Mock Inspections?

No, FDA-regulated companies are not required to conduct mock inspections. However, there are still several reasons to do so. For companies that are eventually going to face scrutiny from the FDA, conducting mock inspections ensures that they know what the FDA is going to find when the time comes. If the FDA would find evidence of non-compliance, conducting mock inspections also affords the opportunity to remedy the company’s compliance failures before they lead to unnecessary costs, delays, and issues with the FDA.

What Types of Companies Should Conduct FDA Mock Inspections?

All types of companies that are subject to the FDA’s oversight should conduct mock inspections. Even if the risk of facing an FDA inspection is relatively low, conducting a mock inspection is still a key step toward assessing (and documenting) the effectiveness of the company’s compliance program. When the risk of facing an FDA inspection is high (or inevitable, such as when a company is seeking pre-market approval), conducting a mock inspection is an essential risk mitigation strategy. With this in mind, we recommend FDA mock inspections for companies in the following FDA-regulated industries:

  • Biologics
  • Cosmetic products 
  • Dietary supplements
  • Food products
  • Medical devices
  • Pharmaceuticals
  • Radiation-emitting electronic devices
  • Tobacco products 
  • Veterinary products

What Are the Risks of Not Conducting an FDA Mock Inspection?

The primary risk of choosing not to conduct an FDA mock inspection is that the FDA will uncover evidence of substantial non-compliance during a real-world inspection. Not only can this lead to denial of a premarket submission, issuance of an untitled letter or warning letter, a request for a recall or market withdrawal, and other financial and non-financial penalties, but it can also increase a company’s risk of facing additional scrutiny from the FDA in the future.

Should I Hire a Law Firm to Conduct an FDA Mock Inspection?

Yes, we strongly recommend engaging a law firm to conduct your company’s FDA mock inspections. While many consulting firms offer mock inspection services, these firms are not permitted to offer legal advice—which is essential when it comes to making informed decisions about FDA compliance.

Where Can I Find an FDA Mock Inspection Checklist?

Although you can find FDA mock inspection checklists online, we strongly advise against using these checklists. While there are several reasons why, one of the most fundamental—and most important—reasons is that these checklists are generic. As a result, they will overlook unique aspects of your company’s FDA-regulated operations, and these aspects are among the most likely to raise concerns during a real-world FDA inspection. When conducting FDA mock inspections, a custom-tailored approach is essential to ensuring that the process serves its intended purpose.


Schedule an Appointment with the FDA Compliance Team at Oberheiden P.C.

If you would like to know more about our mock inspection services for FDA-regulated entities, we encourage you to get in touch. To schedule a complimentary initial consultation with a senior lawyer or consultant at Oberheiden P.C., please call 888-680-1745 or request an appointment online today.

Why Clients Trust Oberheiden P.C.

  • 2,000+ Cases Won
  • Available Nights & Weekends
  • Experienced Trial Attorneys
  • Former Department of Justice Trial Attorney
  • Former Federal Prosecutors, U.S. Attorney’s Office
  • Former Agents from FBI, OIG, DEA
  • Serving Clients Nationwide
Contact Us 888-680-1745 866-781-9539